Platelet Homeostasis is Regulated by Platelet Expression of CD47 Under Normal Conditions and in Passive Immune Thrombocytopenia

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2005 Jan 25

PMID 15665111

Citations 87

Authors

Mattias Olsson

Pierre Bruhns

William A Frazier

Jeffrey V Ravetch

Per-Arne Oldenborg

Affiliations

Soon will be listed here.

Abstract

Interaction between target cell CD47 and the inhibitory macrophage receptor signal regulatory protein alpha (SIRPalpha) counteracts macrophage phagocytosis of CD47-expressing host cells. As platelets also express CD47, we asked whether inhibitory CD47/SIRPalpha signaling regulates normal platelet turnover and clearance of platelets in immune thrombocytopenic purpura (ITP). CD47(-/-) mice had a mild spontaneous thrombocytopenia, which was not due to a decreased platelet half-life as a result of increased expression of P-selectin, CD61, or phosphatidylserine. In contrast, CD47(-/-) platelets were rapidly cleared when transfused into CD47(+/+) recipients, whereas CD47(+/-) platelets had a nearly normal half-life in CD47(+/+) mice under nonautoimmune conditions. CD47(-/-) mice were more sensitive to ITP, as compared with CD47(+/+) mice. In vitro, macrophage phagocytosis of immunoglobulin G (IgG)-opsonized CD47(-/-) platelets was significantly higher than that for equally opsonized CD47(+/+) platelets. However, when SIRPalpha was blocked, phagocytosis of CD47(+/+) platelets increased to the level of CD47(-/-) platelets. Phagocytosis of opsonized CD47(+/-) platelets was higher than that for CD47(+/+) platelets, but lower than that for CD47(-/-) platelets, suggesting a gene-dose effect of CD47 in this system. In conclusion, we suggest that inhibitory CD47/SIRPalpha signaling is involved in regulating platelet phagocytosis in ITP, and that targeting SIRPalpha may be a new means of reducing platelet clearance in ITP.

Citing Articles

CD47 is required for mesenchymal progenitor proliferation and fracture repair.

Zondervan R, Capobianco C, Jenkins D, Reicha J, Fredrick L, Lam C Bone Res. 2025; 13(1):29.

PMID: 40025005 PMC: 11873311. DOI: 10.1038/s41413-025-00409-0.

Nanoparticles for Thrombolytic Therapy in Ischemic Stroke: A Systematic Review and Meta-Analysis of Preclinical Studies.

Prego-Dominguez J, Laso-Garcia F, Palomar-Alonso N, Perez-Mato M, Lopez-Arias E, Dopico-Lopez A Pharmaceutics. 2025; 17(2).

PMID: 40006575 PMC: 11859612. DOI: 10.3390/pharmaceutics17020208.

Biomimetic nanoparticles co-deliver hirudin and lumbrukinase to ameliorate thrombus and inflammation for atherosclerosis therapy.

Cheng M, Yue T, Wang H, Jiang L, Huang Q, Li F Asian J Pharm Sci. 2025; 20(1):100990.

PMID: 39917726 PMC: 11795807. DOI: 10.1016/j.ajps.2024.100990.

Platelet membrane decorated exosomes enhance targeting efficacy and therapeutic index to alleviate arterial restenosis.

Lu S, Wang R, Cai M, Yuan C, Gao B, Guo D Theranostics. 2025; 15(2):408-427.

PMID: 39744678 PMC: 11671393. DOI: 10.7150/thno.103747.

IMM2520, a novel anti-CD47/PD-L1 bispecific antibody for cancer immune therapy.

Yang C, Li S, Chen D, Liu D, Yang Y, Guo H Heliyon. 2024; 10(21):e39858.

PMID: 39553551 PMC: 11564011. DOI: 10.1016/j.heliyon.2024.e39858.

References

Seiffert M, Cant C, Chen Z, Rappold I, Brugger W, Kanz L . Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47. Blood. 1999; 94(11):3633-43. View

Jiang P, Lagenaur C, Narayanan V . Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J Biol Chem. 1999; 274(2):559-62. DOI: 10.1074/jbc.274.2.559. View

Oldenborg P, Zheleznyak A, Fang Y, Lagenaur C, Gresham H, Lindberg F . Role of CD47 as a marker of self on red blood cells. Science. 2000; 288(5473):2051-4. DOI: 10.1126/science.288.5473.2051. View

Ravetch J, Lanier L . Immune inhibitory receptors. Science. 2000; 290(5489):84-9. DOI: 10.1126/science.290.5489.84. View

Samuelsson A, Towers T, Ravetch J . Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science. 2001; 291(5503):484-6. DOI: 10.1126/science.291.5503.484. View

Cant C, Ullrich A . Signal regulation by family conspiracy. Cell Mol Life Sci. 2001; 58(1):117-24. PMC: 11146478. DOI: 10.1007/PL00000771. View

Oldenborg P, Gresham H, Lindberg F . CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis. J Exp Med. 2001; 193(7):855-62. PMC: 2193364. DOI: 10.1084/jem.193.7.855. View

Teeling J, Kuijpers T, de Haas M, van de Winkel J, Hack C, Bleeker W . Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia. Blood. 2001; 98(4):1095-9. DOI: 10.1182/blood.v98.4.1095. View

Blazar B, Lindberg F, Ingulli E, Panoskaltsis-Mortari A, Oldenborg P, Iizuka K . CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells. J Exp Med. 2001; 194(4):541-9. PMC: 2193501. DOI: 10.1084/jem.194.4.541. View

10.

Cines D, Blanchette V . Immune thrombocytopenic purpura. N Engl J Med. 2002; 346(13):995-1008. DOI: 10.1056/NEJMra010501. View

11.

Oldenborg P, Gresham H, Chen Y, Izui S, Lindberg F . Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice. Blood. 2002; 99(10):3500-4. DOI: 10.1182/blood.v99.10.3500. View

12.

Yamao T, Noguchi T, Takeuchi O, Nishiyama U, Morita H, Hagiwara T . Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1. J Biol Chem. 2002; 277(42):39833-9. DOI: 10.1074/jbc.M203287200. View

13.

Coopamah M, Garvey M, Freedman J, Semple J . Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update. Transfus Med Rev. 2003; 17(1):69-80. DOI: 10.1053/tmrv.2003.50004. View

14.

Hoffmeister K, Felbinger T, Falet H, Denis C, Bergmeier W, Mayadas T . The clearance mechanism of chilled blood platelets. Cell. 2003; 112(1):87-97. DOI: 10.1016/s0092-8674(02)01253-9. View

15.

Song S, Crow A, Freedman J, Lazarus A . Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG. Blood. 2002; 101(9):3708-13. DOI: 10.1182/blood-2002-10-3078. View

16.

Crow A, Song S, Freedman J, Helgason C, Humphries R, Siminovitch K . IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity. Blood. 2003; 102(2):558-60. DOI: 10.1182/blood-2003-01-0023. View

17.

Rand M, Wang H, Bang K, Poon K, Packham M, Freedman J . Procoagulant surface exposure and apoptosis in rabbit platelets: association with shortened survival and steady-state senescence. J Thromb Haemost. 2004; 2(4):651-9. DOI: 10.1111/j.1538-7836.2004.00670.x. View

18.

Oldenborg P . Role of CD47 in erythroid cells and in autoimmunity. Leuk Lymphoma. 2004; 45(7):1319-27. DOI: 10.1080/1042819042000201989. View

19.

McMillan R, Tani P, Millard F, Berchtold P, Renshaw L, Woods Jr V . Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood. 1987; 70(4):1040-5. View

20.

Mizutani H, Engelman R, Kurata Y, Ikehara S, GOOD R . Development and characterization of monoclonal antiplatelet autoantibodies from autoimmune thrombocytopenic purpura-prone (NZW x BXSB)F1 mice. Blood. 1993; 82(3):837-44. View